Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers

Khalique, S; Naidoo, K; Attygalle, AD; Kriplani, D; Daley, F; Lowe, A; Campbell, J; Jones, T; Hubank, M; Fenwick, K; Matthews, N; Rust, AG; Lord, CJ; Banerjee, S; Natrajan, R

Banerjee, S (reprint author), Royal Marsden NHS Fdn Trust, Gynaecol Unit, 203 Fulham Rd, London SW3 6JJ, England.; Natrajan, R (reprint author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Mary Jean Mitchell Green Bldg,237 Fulham Rd, London SW3 6J

JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2018; 4 (3): 154

Abstract

ARID1A is a tumour suppressor gene that is frequently mutated in clear cell and endometrioid carcinomas of the ovary and endometrium and is an importa......

Full Text Link